These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24702116)

  • 41. [Use of testosterone and anabolic androgenic steroids in sport].
    Medraś M; Jóźków P
    Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of alternative gas chromatographic and mass spectrometric behaviour of trimethylsilyl-derivatives of non-hydrolysed sulfated anabolic steroids.
    Albertsdóttir AD; Van Gansbeke W; Van Eenoo P; Polet M
    Drug Test Anal; 2023; 15(11-12):1344-1355. PubMed ID: 36843396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse.
    Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS
    Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening hybridomas for anabolic androgenic steroids by steroid analog antigen microarray.
    Du H; Chen G; Bian Y; Xing C; Ding X; Zhu M; Xun Y; Chen P; Zhou Y; Li S
    Bioanalysis; 2015; 7(10):1201-9. PubMed ID: 25973986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Doping--also a problem in general practice?].
    Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
    Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.
    Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C
    Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping.
    Solimini R; Rotolo MC; Mastrobattista L; Mortali C; Minutillo A; Pichini S; Pacifici R; Palmi I
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):7-16. PubMed ID: 28379599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgens, sports, and detection strategies for anabolic drug use.
    Walpurgis K; Piper T; Thevis M
    Best Pract Res Clin Endocrinol Metab; 2022 Jul; 36(4):101609. PubMed ID: 35120801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ongoing medical problems in the anti-doping fight].
    Delagardelle C; Ries F; Feiereisen P; Urhausen A
    Bull Soc Sci Med Grand Duche Luxemb; 2007; (2):109-24. PubMed ID: 18084907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes.
    Karila T; Hovatta O; Seppälä T
    Int J Sports Med; 2004 May; 25(4):257-63. PubMed ID: 15162244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short QT interval is unreliable marker of anabolic androgenic steroid abuse in competitive athletes.
    Djordjević V; Stanković I; Stipac AV; Putniković B; Nesković AN
    Srp Arh Celok Lek; 2012; 140(11-12):711-6. PubMed ID: 23350243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Doping: effectiveness, consequences, prevention].
    Guezennec CY
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modern techniques for the determination of anabolic-androgenic steroid doping in the horse.
    McKinney AR
    Bioanalysis; 2009 Jul; 1(4):785-803. PubMed ID: 21083138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of anabolic androgenic steroids in serum samples.
    Makvandi B; Pohanka A; Bergström M; Börjesson A; Lehtihet M; Ekström L; Zheng Y
    Drug Test Anal; 2023 Jun; 15(6):678-688. PubMed ID: 36987780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgenic-anabolic steroids abuse in males.
    Di Luigi L; Romanelli F; Lenzi A
    J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry.
    Pozo OJ; Deventer K; Eenoo PV; Delbeke FT
    Anal Chem; 2008 Mar; 80(5):1709-20. PubMed ID: 18220370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
    Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
    Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.